Residual risk for clinically significant copy number variants in low-risk pregnancies, following exclusion of NIPS-detectable findings.
Sign Up to like & getrecommendations! Published in 2021 at "American journal of obstetrics and gynecology"
DOI: 10.1016/j.ajog.2021.11.016
Abstract: BACKGROUND Chromosomal microarray analysis (CMA) detects clinically significant copy number variants (CNVs) in about 1% of low-risk pregnancies. As the constantly growing wide use of non-invasive prenatal screening (NIPS) facilitates the detection of chromosomal aberrations,… read more here.
Keywords: risk; risk clinically; clinically significant; nips detectable ... See more keywords